Ibex Showcases Diagnostic Efficiency of AI in Prostate, Breast, and Gastric Cancer
Ibex’s Galen platform aims to help labs overcome the challenges of increasing demand and diagnostic workloads for cancer diagnostics.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Cancer |
Ibex’s Galen platform aims to help labs overcome the challenges of increasing demand and diagnostic workloads for cancer diagnostics.
Read MorePosted by Andy Lundin | Aug 1, 2023 | Prostate |
A new study demonstrated Decipher Prostate Genomic Classifier’s ability to guide personalized treatment for men with prostate cancer.
Read MorePosted by Andy Lundin | Mar 3, 2023 | Urine Analyzers |
Researchers developed a urine sensor that can amplify the light signal of metabolites in urine and in diagnosing cancer in the field.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Uncategorized |
Enumeration of CTCs may be useful for determining long-term prognosis in patients with metastatic castration-sensitive prostate cancer and breast cancer.
Read MorePosted by Elaine Sanchez Wilson | May 11, 2018 | Lung Cancer, Prostate |
Qiagen has launched two novel liquid biopsy panels for the evaluation of circulating tumor cells, in the growing field of research into the molecular mechanisms of prostate and lung cancers.
Read More